Mouth Neoplasms: all 381 studies
Page 3 of 4. Open to participants first (126), then studies with results posted, then the rest; newest registration first within each.
- A Pilot Study of Additional Chinese Formula for Concurrent Chemoradiotherapy in Oral Cavity Cancer PatientsCompletedNCT05590650Phase 1
- A Pneumatic Compression Device for the Treatment of Lymphedema in Patients With Stage II-IV Head and Neck Cancer After ChemoradiationWithdrawnNCT05512767Not applicable
- Mass Response of Tumor Cells as a Biomarker for Rapid Therapy Guidance (TraveraRTGx)CompletedNCT05461430
- Therapeutic Efficacy of Quercetin Versus Its Encapsulated Nanoparticle on Tongue Squamous Cell Carcinoma Cell LineStatus unknownNCT05456022Phase 2
- Preoperative Music Listening in Odontostomatological Surgery (PMLOS)CompletedNCT05417529Not applicable
- the Oncogenic Potential of Salivary miRNA-93 and miRNA-412-3P in Oral Lichen Planus PatientsCompletedNCT05400057
- Effects of Oral Aloe Vera Juice on Chemotherapy and Radiation-induced Oral Mucositis and EsophagitisCompletedNCT05369234Phase 3
- Safety and Efficacy of APG-157 in Head and Neck CancerActive, not recruitingNCT05312710Phase 2
- Lateral Arm Free Flap for Reconstruction of the Oral Cavity and Head and Neck Soft Tissue Defects.Status unknownNCT05296811Not applicable
- The Efficacy of Mouth Exercise in Oral Cancer Patients After Receiving SurgeryCompletedNCT05227807Not applicable
- Testing the Addition of an Anti-cancer Drug, Ipatasertib, to the Usual Immunotherapy Treatment (Pembrolizumab) in Patients With Recurrent or Metastatic Squamous Cell Cancer of the Head and NeckActive, not recruitingNCT05172258Phase 2
- Improved Implant for Reconstruction Purposes After Mandibular ResectionTerminatedNCT05153733Not applicable
- Intensity Modulated Proton or X-Ray Therapy After Surgery for Treatment of Head and Neck Cancer, the HEADLIGHT StudyActive, not recruitingNCT05075980Phase 2
- Testing the Use of Investigational Drugs Atezolizumab and/or Bevacizumab With or Without Standard Chemotherapy in the Second-Line Treatment of Advanced-Stage Head and Neck CancersActive, not recruitingNCT05063552Phase 2/3
- Efficacy of Swallowing Function After Early Postoperative Oral Exercise Among Patient With Oral Cavity Cancer Underwent Flap ReconstructionCompletedNCT05056064Not applicable
- Verification of Saliva MMP-1 as a Diagnostic Marker of Oral Cavity CancerCompletedNCT05049408
- Exfoliated Cytology in Detection of Oral Premalignant and Malignant LesionsStatus unknownNCT04955197
- The Oral Microbiome in OSCCCompletedNCT04925700Not applicable
- Research on Optimization and Evaluation of Oral Cancer Screening MethodsStatus unknownNCT04919460Early Phase 1
- A Study of Concurrent Chemoradiation in Combination With or Without PD1 Inhibitor AB122 Adenosine 2a Receptor / Adenosine 2b Receptor Inhibitor AB928 Therapies in Locally Advanced Head and Neck CancersWithdrawnNCT04892875Phase 1
- Customized 3D Printed Oral Stents During Head and Neck RadiotherapyActive, not recruitingNCT04870762Phase 2
- Cemiplimab, Low-Dose Paclitaxel and Carboplatin for the Treatment of Recurrent/Metastatic Squamous Cell Carcinoma of the Head and NeckActive, not recruitingNCT04862650Phase 2
- SPIO-enhanced MRI in Oral Cancer for Sentinel Lymph Node IdentificationStatus unknownNCT04803331Not applicable
- Diagnostic Accuracy of Salivary Gamma-synuclein in Oral Malignant and Premalignant LesionsStatus unknownNCT04732741
- Photobiomodulation in Oral Lesions Resulting From Anti-neoplastic PreventionCompletedNCT04717765Not applicable
- Enhancing Self Care Among Oral Cancer Survivors: The Empowered Survival TrialActive, not recruitingNCT04713449Not applicable
- Understanding Non-radiotherapy-based Development of TrismusStatus unknownNCT04670146Not applicable
- Effects of Oral Cancer Treatments on Upper Esophageal Opening During SwallowingTerminatedNCT04658342
- Green Tea Mouthwash on the Oral Health Status in Oral Cancer PatientsCompletedNCT04615780Not applicable
- Use of Ultrasound for Measuring Size of Oral Tongue CancersCompletedNCT04614896Not applicable
- Testing the Addition of M3814 (Peposertib) to Radiation Therapy for Patients With Advanced Head and Neck Cancer Who Cannot Take CisplatinActive, not recruitingNCT04533750Phase 1
- Evaluating Oral Visual Inspection in the Control of Oral CancerCompletedNCT04494620Not applicable
- Oral Cancer Screening and Education in Hong KongStatus unknownNCT04487938
- Effects of Electromyographic Visual Feedback for Spinal Accessory Nerve Dysfunction After Neck DissectionCompletedNCT04476004Not applicable
- Neoadjuvant Toripalimab and Paclitaxel/Cisplatin on Pathological Response in Oral Squamous Cell Carcinoma PatientsCompletedNCT04473716Phase 1
- NBI in Oral Cavity CancerCompletedNCT04398121
- Inductive Camrelizumab and Apatinib for Patients With Locally Advanced and Resectable Oral Squamous Cell CarcinomaCompletedNCT04393506Phase 1
- Radiotherapy of Head and Neck Cancer Using an Intraoral StentCompletedNCT04330781Phase 2
- Malondialdehyde and Nitrous Oxide as Salivary Biomarkers for Different Oral LesionsCompletedNCT04267419
- Evaluation of the Photobiomodulation Using LED Lamp for Curative Treatment of Radio-induced Mucositis.CompletedNCT04251949Phase 2
- Personalized Survivor Care Plan for Oral Cancer Patients-Effects on Physical-Psychological Functions and Return-to-WorkStatus unknownNCT04214912Not applicable
- Fluorescence-guided Surgery Using cRGD-ZW800-1 in Oral CancerCompletedNCT04191460Phase 2
- Oral Care Study of Postoperative InfectionsStatus unknownNCT04163029
- Quality of Life in Patients Treated for Tongue and/or Jaw Neoplasia Before and After Speech TherapyCompletedNCT04126226Not applicable
- Dental Hygienists and Dentists as Providers of Oral Mucosa Screening and Brush BiopsiesCompletedNCT04081038
- Sintilimab to Prevent High-risk Oral Premalignant Lesions CancerizationStatus unknownNCT04065737Phase 2
- Using an APP in Post Oral Cancer Surgery to Affect Patients' Needs and Quality of Life.CompletedNCT04049968Not applicable
- Oral Stent Device for Radiation Treatments of Oral CancersWithdrawnNCT04041141
- A New Membrane Obturator Prothesis Concept for Soft Palate DefectsCompletedNCT04009811Not applicable
- Cell-free Tumor DNA in Head and Neck Cancer PatientsStatus unknownNCT03942380Not applicable
- Acupuncture Effect on Digestion in Critically Ill Post-Operative Oral and Hypo-pharyngeal Cancer PatientsCompletedNCT03934294Not applicable
- Adjuvant ChemoRadiotherapy Prior to Surgery in Stage IVa Oral CancersCompletedNCT03923998Early Phase 1
- MSOT Using Cetuximab-800CW for Detection of Cervical Lymph Node MetastasesStatus unknownNCT03923881Not applicable
- Jaw Reconstruction With Printed Titanium and Free Tissue TransferCompletedNCT03905005
- Analysis of the Variation in Caspase-8 Availability and Cleavage in Oral Squamous Cell CarcinomaStatus unknownNCT03877159
- Memory Phenotype and PD-1 Inhibition Response in Oral CancerTerminatedNCT03862066
- EHR-embedded OCDT in Breast or GI CancerCompletedNCT03858712Not applicable
- Adjuvant Radiotherapy in Early Stage Oral CancersCompletedNCT03853655Not applicable
- Neoadjuvant Nivolumab for Oral Cancer Combined With FDG and Anti-PD-L1 PET/CT Imaging for Response PredictionStatus unknownNCT03843515Phase 1
- Oral Cancer With Wide Excision and Free Flap ReconstructionStatus unknownNCT03776578
- CA209-891: Neoadjuvant and Adjuvant Nivolumab as Immune Checkpoint Inhibition in Oral Cavity CancerCompletedNCT03721757Phase 2
- Sensitivity and Specificity of Serum and Salivary CYFRA21-1 in the Detection of Malignant Transformation in Oral Potentially Malignant Mucosal Lesions (Diagnostic Accuracy Study)Status unknownNCT03686020
- Cancer Chemoprevention by Metformin Hydrochloride in Oral Potentially Malignant LesionsStatus unknownNCT03685409Phase 3
- Cancer Chemoprevention by Metformin Hydrochloride Compared to Placebo in Oral Potentially Malignant LesionsStatus unknownNCT03684707Phase 4
- Diagnostic Accuracy of Salivary DNA Integrity Index in Oral Malignant and Premalignant LesionsCompletedNCT03682562
- Comparison Between a Standard Tube and the Ultra-thin Tritube for Intubation of the Trachea and for Maintaining Access to the Trachea After Anaesthesia, in Patients With an Expected Difficult Direct LaryngoscopyCompletedNCT03653039Not applicable
- Improving Access to Control of Diseases for WomenCompletedNCT03604939Not applicable
- Study of A166 in Patients With Relapsed/Refractory Cancers Expressing HER2 Antigen or Having Amplified HER2 GeneCompletedNCT03602079Phase 1/2
- NBTXR3 Activated by Radiotherapy for Patients With Advanced Cancers Treated With An Anti-PD-1 TherapyActive, not recruitingNCT03589339Phase 1
- Sitravatinib (MGCD516) and Nivolumab in Oral Cavity Cancer Window Opportunity StudyCompletedNCT03575598Early Phase 1
- Nivolumab & IRX-2 With Surgery for Resectable Stage III-IVA Oral Cavity Cancer or HPV-Positive Oropharyngeal CancerWithdrawnNCT03575234Phase 1
- CytID Analysis of Oral LesionsTerminatedNCT03555721
- Rehabilitation Outcomes of Shoulder Function in Oral Cancer Survivors Cancer SurvivorsCompletedNCT03545100Not applicable
- Salivary Ap4A, SCCA, TROP2 in Oral Cancer PatientsStatus unknownNCT03529604
- Donor Natural Killer Cells, Cyclophosphamide, and Etoposide in Treating Children and Young Adults With Relapsed or Refractory Solid TumorsTerminatedNCT03420963Phase 1
- Chemoradiation vs Immunotherapy and Radiation for Head and Neck CancerActive, not recruitingNCT03383094Phase 2
- The Oral Microbiome and Upper Aerodigestive Squamous Cell CancerCompletedNCT03304132
- Impact of Compliance With Fluoride Use on Caries Incidence After Cancer TherapyCompletedNCT03267914Not applicable
- Nivolumab or Expectant Observation Following Ipilimumab, Nivolumab, and Surgery in Treating Patients With High Risk Localized, Locoregionally Advanced, or Recurrent Mucosal MelanomaWithdrawnNCT03220009Phase 2
- Physical Activities by Technology Help (PATH)CompletedNCT03212079Not applicable
- Rehabilitation Outcomes in Head and Neck SurvivorsCompletedNCT03206242
- Innovative Approach to Triage Oral PrecancerStatus unknownNCT03202810
- Adaptive Radiotherapy for Head and Neck CancerCompletedNCT03096808Phase 2
- A Novel Robotic System for Single Port and Natural Orifice Transluminal Endoscopic SurgeryCompletedNCT03010813Not applicable
- Effect of FDG-PET/CT for Simulation and Radiation Treatment Planning in Oral Cancer PatientsStatus unknownNCT03008694Phase 2
- CaptHPV : Validation of the Method "CaptHPV" for the Diagnosis of Human Papillomavirus Associated Infiltrating CarcinomasCompletedNCT02981862Not applicable
- uPAR PET/CT for Staging Advanced and Localised Oral and Oropharyngeal CancerStatus unknownNCT02960724Phase 2
- Study of Pre-operative Combination Therapy With Mogamulizumab and Nivolumab Against Solid Cancer PatientsCompletedNCT02946671Phase 1
- Postoperative CCRT With Docetaxel vs Cisplatin in High Risk Oral Cavity CancerCompletedNCT02923258Phase 2/3
- Participatory Research for Fine-tuning of a 2.0 System to Optimise Home Management of Oral Cancer Therapies.Status unknownNCT02921724Not applicable
- Validation of DNA Methylation Biomarkers for Oral Cancer Detection-Follow up StudyStatus unknownNCT02902406
- Oral State of Patients Affected by an Oral Cancer Before and After Radiotherapy - 3-years Prospective StudyStatus unknownNCT02866500Not applicable
- Nivolumab and Ipilimumab in Treating Patients With Rare TumorsActive, not recruitingNCT02834013Phase 2
- Multimodal Imaging for Surveillance in Patients With Oral Potentially Malignant DisordersActive, not recruitingNCT02790853Early Phase 1
- Intensity-Modulated Proton Therapy (IMPT) or TransOral Robotic Surgery (TORS) for the Treatment of Low-Risk Oropharynx Squamous CellStatus unknownNCT02663583
- Validation of DNA Methylation Biomarkers for Oral Cancer DetectionCompletedNCT02648789
- Cytological Screening for Early Diagnosis of Precancerous or Cancerous Lesions of Oral CavityCompletedNCT02604121Not applicable
- Sentinel Lymph Node Mapping of Oral Cancer Using Near-Infrared Fluorescence ImagingCompletedNCT02478138Not applicable
- Establishing Lymphedema and Fibrosis Measures in Oral Cancer PatientsCompletedNCT02412241Not applicable
- Salivary and Serum Levels of Chemerin and MMP-9 in Oral Premalignant and Malignant LesionsCompletedNCT02323672